IL10 and neoplasm: Similarly, the expression of Il10, which encodes another anti-inflammatory pro-tumor marker, was slightly upregulated (up to four-fold compared to HS) in the RLS40Low and RLS40Med subgroups and at the level of healthy control (HS) in the RLS40High and RLS40/D subgroups (Figure 5C).